Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress

NEXT STORY
CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress
PREV STORY
Vaxcyte Announces Pricing of Upsized Initial Public Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody

Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company ...

author_avatar
NASDAQ Market News

Cancer Genetics, Inc. Chief Executive Officer Steps Down

•   Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals to Release Third Quarter 2016 Financial Results

BERKELEY HEIGHTS, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

author_avatar
NASDAQ Market News